FDA grants speedy approval to Eli Lilly’s weight-loss pill for obesity

Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted expedited approval to orforglipron, a GLP-1 drug that works like widely used injectable medication...

Redirecting to full article...